Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PUT
PepsiCo
PEP
$197B
| $714K | ﹤0.01% |
4,200
-18,200
| -81% | -$3.13M |
|
1077
Bain Capital Specialty
BCSF
$786M
| $711K | ﹤0.01% |
42,833
-35,167
| -45% | -$583K |
|
1078
Lufax Holding
LU
$1.17B
| $709K | ﹤0.01% |
+203,261
| New | +$532K |
|
|
BRY
1079
DELISTED
Berry Corp
BRY
| $706K | ﹤0.01% |
137,352
-43,737
| -24% | -$267K |
|
1080
Mativ Holdings
MATV
$676M
| $706K | ﹤0.01% |
+41,557
| New | +$730K |
|
1081
Winmark
WINA
$1.26B
| $705K | ﹤0.01% |
1,842
-51
| -3% | -$19K |
|
1082
Hims & Hers Health
HIMS
$7.25B
| $702K | ﹤0.01% |
38,102
-9,262
| -20% | -$166K |
|
1083
Pennant Group
PNTG
$1.36B
| $702K | ﹤0.01% |
19,651
+9,305
| +90% | +$286K |
|
|
DNB
1084
DELISTED
Dun & Bradstreet
DNB
| $696K | ﹤0.01% |
60,482
-105,049
| -63% | -$1.17M |
|
1085
Superior Group of Companies
SGC
$203M
| $695K | ﹤0.01% |
+44,858
| New | +$731K |
|
1086
Marqeta
MQ
$1.7B
| $693K | ﹤0.01% |
+35,194
| New | +$736K |
|
|
BECN
1087
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $690K | ﹤0.01% |
+7,986
| New | +$711K |
|
|
B
1088
Barrick Mining
B
$79.3B
| $686K | ﹤0.01% |
+34,502
| New | +$657K |
|
1089
CVB Financial
CVBF
$3.95B
| $685K | ﹤0.01% |
+38,416
| New | +$685K |
|
|
PCH
1090
DELISTED
PotlatchDeltic
PCH
| $684K | ﹤0.01% |
+15,189
| New | +$643K |
|
1091
Cohen & Steers
CNS
$4.28B
| $681K | ﹤0.01% |
7,094
-1,798
| -20% | -$153K |
|
1092
Brown & Brown
BRO
$25B
| $677K | ﹤0.01% |
+6,535
| New | +$650K |
|
|
BLUE
1093
DELISTED
bluebird bio
BLUE
| $674K | ﹤0.01% |
+64,833
| New | +$1.08M |
|
1094
KRONOS Worldwide
KRO
$1B
| $674K | ﹤0.01% |
54,154
+43,706
| +418% | +$506K |
|
1095
Advanced Energy
AEIS
$11B
| $673K | ﹤0.01% |
6,392
-36,996
| -85% | -$3.88M |
|
|
SYRS
1096
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $673K | ﹤0.01% |
313,004
+49,313
| +19% | +$177K |
|
|
PINC
1097
DELISTED
Premier
PINC
| $667K | ﹤0.01% |
+33,329
| New | +$662K |
|
1098
Element Solutions
ESI
$8.52B
| $665K | ﹤0.01% |
+24,502
| New | +$642K |
|
1099
PUT
Bank of America
BAC
$436B
| $663K | ﹤0.01% |
16,700
-110,200
| -87% | -$4.42M |
|
1100
LKQ Corp
LKQ
$6.51B
| $662K | ﹤0.01% |
16,585
-111,569
| -87% | -$4.6M |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.